Controlling the cellular organization of tissue-engineered cardiac constructs

被引:36
作者
Gonen-Wadmany, M
Gepstein, L
Seliktar, D [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Physiol, Cardiovasc Res Lab, IL-32000 Haifa, Israel
来源
CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION | 2004年 / 1015卷
关键词
cardiomyocytes; collagen hydrogel; bioreactor; mechanical stimulation; in vitro development;
D O I
10.1196/annals.1302.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There are currently no effective treatments to restore the cardiac muscle lost because of ischemia for the millions of people who suffer heart attacks annually. Cell therapy procedures have emerged as novel therapeutic strategies for treatment of heart failure after myocardial infarction but have been hampered by the lack of adequate cell sources of cardiomyocytes and by the inability to integrate cell grafts into cardiac muscle. A cardiac patch composed of organized and functional cardiomyocytes could drastically enhance the efficacy of this important clinical approach. Here, we report our ongoing efforts to develop a bioartificial cardiac muscle capable of synchronized multidirectional contraction within a three-dimensional hydrogel scaffold. Neonatal rat cardiomyocytes, smooth muscle cells, and reconstituted polymeric collagen enriched with growth factors and hormones are used. A bioreactor system is used to impart precise strains onto the developing tissue constructs in vitro. The results demonstrate that cell-mediated collagen compaction is significantly enhanced by strain preconditioning, resulting in a more favorable cellular organization. Furthermore, the results demonstrate that strain stimulation guides cellular orientation in the direction of applied strain (i.e., in the circumferential direction). Hence, we demonstrate the importance of mechanical preconditioning as a means of promoting the in vitro development of engineered cardiac muscle for use with myocardial regeneration therapies.
引用
收藏
页码:299 / 311
页数:13
相关论文
共 24 条
  • [1] Cohn JN, 1997, CIRCULATION, V95, P766
  • [2] EHRLICH HP, 1986, J CELL SCI, V82, P281
  • [3] Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction
    Etzion, S
    Battler, A
    Barbash, IM
    Cagnano, E
    Zarin, P
    Granot, Y
    Kedes, LH
    Kloner, RA
    Leor, J
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (07) : 1321 - 1330
  • [4] Derivation and potential applications of human embryonic stem cells
    Gepstein, L
    [J]. CIRCULATION RESEARCH, 2002, 91 (10) : 866 - 876
  • [5] IMBERTI B, 2002, ENDOTHELIUM, V9, P9
  • [6] Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts
    Klug, MG
    Soonpaa, MH
    Koh, GY
    Field, LJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) : 216 - 224
  • [7] Leor J, 1996, CIRCULATION, V94, P332
  • [8] Li RK, 1997, CIRCULATION, V96, P179
  • [9] Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes
    Meiry, G
    Reisner, Y
    Feld, Y
    Goldberg, S
    Rosen, M
    Ziv, N
    Binah, O
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (11) : 1269 - 1277
  • [10] Skeletal myoblast transplantation for repair of myocardial necrosis
    Murry, CE
    Wiseman, RW
    Schwartz, SM
    Hauschka, SD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) : 2512 - 2523